Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer
YM Tsai, KH Lin, YS Kuo, YC Lin… - Formosan Journal of …, 2022 - journals.lww.com
Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …
Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer.
YM Tsai, KH Lin, YS Kuo, YC Lin… - … Journal of Surgery, 2022 - search.ebscohost.com
Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …
[PDF][PDF] Clinical significance of epidermal growth factor receptor mutations in resected stage IA non‑small cell lung cancer
YM Tsai, KH Lin, YS Kuo, YC Lin, YH Chien, HP Chou… - 2022 - researchgate.net
Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …